NCT06281665View on ClinicalTrials.gov

Treatment With Aspirin After Preeclampsia: TAP Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 29, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2027

Conditions
Hypertensive Disorder of PregnancyPre-EclampsiaHypertensionEclampsiaGestational HypertensionCardiovascular DiseasesToxemiaPregnancy ComplicationsVascular DiseasesHypertension, Pregnancy InducedHypertension;Pre-Eclamptic
Interventions
DRUG

Low-dose aspirin

The intervention group will receive low-dose \[81 mg\] aspirin pill daily for 6 months.

DRUG

Placebo

The control group will receive similar appearing placebo daily for 6 months.

Trial Locations (1)

15213

RECRUITING

University of Pittsburgh Magee-Womens Hospital, Pittsburgh

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Alisse Hauspurg

OTHER